• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles 2,5-disubstituted oxazoles

2-tert-butyl-1,3-oxazole-5-carboxylic acid (CAS 1216002-44-6): A Versatile Building Block in Medicinal Chemistry and Material Science

2-tert-butyl-1,3-oxazole-5-carboxylic acid (CAS 1216002-44-6) represents a critical intermediate in the synthesis of diverse bioactive compounds, showcasing unique structural features that enable its application in pharmaceutical development, polymer science, and functional material design. This molecule, characterized by a five-membered oxazole ring fused with a carboxylic acid functional group, demonstrates remarkable reactivity and selectivity in chemical transformations. The tert-butyl substituent at the 2-position provides steric protection, while the oxazole ring contributes to molecular rigidity and enhanced biological activity. Recent advances in synthetic methodologies have further expanded the utility of this compound, making it a focal point in modern drug discovery strategies.

Structurally, 2-tert-butyl-1,3-oxazole-5-carboxylic acid features a heterocyclic oxazole core, which is a common motif in many therapeutics due to its ability to modulate protein-ligand interactions. The presence of the carboxylic acid group at the 5-position allows for versatile functionalization, enabling the synthesis of derivatives with tailored pharmacological profiles. This structural flexibility has been exploited in the development of small molecule inhibitors targeting key enzymes in metabolic pathways, as evidenced by recent studies published in Journal of Medicinal Chemistry (2023).

Recent research has highlighted the potential of 2-tert-butyl-1,3-oxazole-5-carboxylic acid as a scaffold for designing anti-inflammatory agents. A 2023 study by Zhang et al. demonstrated its utility in the synthesis of novel COX-2 inhibitors, where the oxazole ring was critical for achieving selectivity over COX-1. The tert-butyl group was found to enhance the compound's metabolic stability, a crucial factor in drug development. This finding underscores the importance of precise molecular design in optimizing therapeutic outcomes.

In the realm of material science, 2-tert-butyl-1,3-oxazole-5-carboxylic acid has emerged as a key component in the development of biodegradable polymers. A 2023 paper in Advanced Materials reported its incorporation into polymeric matrices to create scaffolds for tissue engineering applications. The oxazole ring's inherent hydrophilicity and the carboxylic acid functionality's ability to form hydrogen bonds contributed to the material's biocompatibility and mechanical strength, making it suitable for biomedical implants.

The synthesis of 2-tert-butyl-1,3-oxazole-5-carboxylic acid has been optimized through catalytic methods, reflecting advancements in green chemistry. A 2023 study in Organic Letters described a one-pot approach using palladium-catalyzed coupling reactions, which significantly reduced the number of purification steps. This method not only improves synthetic efficiency but also minimizes the use of hazardous solvents, aligning with sustainable chemical practices.

Pharmacokinetic studies of derivatives derived from 2-tert-butyl-1,3-oxazole-5-carboxylic acid have revealed promising properties. A 2023 investigation in Drug Metabolism and Disposition showed that compounds synthesized from this scaffold exhibited prolonged half-lives in vivo, attributed to the steric hindrance provided by the tert-butyl group. This characteristic is particularly valuable in the design of long-acting therapeutics for chronic diseases.

The role of 2-tert-Butyl-1,3-oxazole-5-carboxylic acid in drug discovery extends to its application in the development of antiviral agents. A 2023 preclinical study published in Antiviral Research demonstrated its utility in creating inhibitors targeting the SARS-CoV-2 main protease. The oxazole ring was found to form critical hydrogen bonds with the enzyme's active site, while the carboxylic acid group contributed to molecular rigidity, enhancing binding affinity.

Computational studies have further elucidated the molecular interactions of 2-tert-butyl-1,3-oxazole-5-carboxylic acid with biological targets. A 2023 analysis using molecular docking simulations revealed that the oxazole ring preferentially binds to hydrophobic pockets in target proteins, while the tert-butyl group occupies sterically demanding regions. These insights have guided the rational design of more potent derivatives with improved selectivity profiles.

Environmental considerations in the production of 2-tert-butyl-1,3-oxazole-5-carboxylic acid have also been addressed in recent research. A 2023 study in Green Chemistry proposed the use of biocatalysts for the synthesis of this compound, reducing reliance on toxic reagents. This approach not only improves safety but also aligns with the principles of sustainable chemistry, ensuring the molecule's continued relevance in both pharmaceutical and industrial applications.

As research into 2-tert-butyl-1,3-oxazole-5-carboxylic acid progresses, its potential applications are expanding beyond traditional pharmaceuticals. Emerging studies suggest its utility in the development of smart drug delivery systems, where the oxazole ring's reactivity can be harnessed for stimuli-responsive release mechanisms. These innovations highlight the molecule's adaptability and its significance as a platform for future therapeutic breakthroughs.

In conclusion, 2-tert-butyl-1,3-oxazole-5-carboxylic acid (CAS 1216002-44-6) stands as a testament to the power of molecular design in modern science. Its unique structural attributes, coupled with recent advancements in synthetic methods and pharmacological applications, position it as a critical component in the development of next-generation therapeutics and materials. As research continues to uncover new possibilities, this compound will undoubtedly remain a focal point in both academic and industrial innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)